Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
June 14, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-333 demonstrated initial clinical proof of concept across multiple hematological malignancies, including complete responses in two patients with Hodgkin’s lymphoma Robust STAT3 knockdown and...
Deposco Garners 2024 SupplyTech Breakthrough Award For “3PL Innovation Of The Year”
June 13, 2024 08:02 ET
|
SupplyTech Breakthrough
LOS ANGELES, June 13, 2024 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products...
AGBA/Triller $4bn Merger: The Group files its Preliminary Proxy Statement
June 12, 2024 08:20 ET
|
AGBA Group Holding Ltd
LOS ANGELES, June 12, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), reports that on June 12, 2024, the company filed its preliminary...
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS)
June 03, 2024 12:00 ET
|
Crinetics Pharmaceuticals, Inc.
100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg) CAH Participants Achieved More Than a 90% Reduction of...
Overland AI Secures $10M in Seed Funding to Accelerate Development of Autonomous Vehicle Software for High-Risk Missions
May 20, 2024 12:00 ET
|
Overland AI
SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) -- Overland AI, a Seattle-based pioneer in off-road ground vehicle autonomy for the defense sector, today announced it has secured $10 million in seed funding,...
Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
May 14, 2024 10:00 ET
|
Kymera Therapeutics, Inc.
Abstract released today highlights safety, pharmacodynamic and clinical response data collected through February 6, 2024 cut-off date Updated data to be presented at the European Hematology...
IPG’s Commonwealth//McCann Recognized as GM Supplier of Year
April 17, 2024 17:15 ET
|
Interpublic Group of Companies, Inc. (The)
New York, April 17, 2024 (GLOBE NEWSWIRE) -- General Motors has recognized Interpublic Group’s (NYSE: IPG) Commonwealth//McCann as one of its top global suppliers of 2023 during its annual Supplier...
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
April 08, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
New preclinical data on novel E3 pairing and structural mechanisms for KT-333, a First-in-Class STAT3 degrader, presented in AACR’s late-breaking poster session Nello Mainolfi, Founder, President and...
Overland AI Awarded $18.6 Million-ceiling Prototype OT to Develop Autonomous Navigation for U.S. Army’s Robotic Combat Vehicles
April 03, 2024 15:38 ET
|
Overland AI
SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Overland AI, innovators in artificial intelligence (AI) and robotics for autonomous navigation and transportation, today announced the startup has...
Automobile Industry’s Demand for Efficiency Boosting the Heat Shield Market is anticipated to have reached a value of US$ 8.9 Billion by 2034 | Future Market Insights
March 28, 2024 12:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 28, 2024 (GLOBE NEWSWIRE) -- The global heat shield market is expected to be valued at US$ 5.0 billion in 2024. The progress of the market is projected to be sturdy over the...